331 related articles for article (PubMed ID: 14508385)
21. Mycophenolic acid and mycophenolic acid glucuronide pharmacokinetics in pediatric liver transplant recipients: effect of cyclosporine and tacrolimus comedication.
Brown NW; Aw MM; Mieli-Vergani G; Dhawan A; Tredger JM
Ther Drug Monit; 2002 Oct; 24(5):598-606. PubMed ID: 12352931
[TBL] [Abstract][Full Text] [Related]
22. Mycophenolic acid exposure after administration of mycophenolate mofetil in the presence and absence of cyclosporin in renal transplant recipients.
Kuypers DR; Ekberg H; Grinyó J; Nashan B; Vincenti F; Snell P; Mamelok RD; Bouw RM
Clin Pharmacokinet; 2009; 48(5):329-41. PubMed ID: 19566116
[TBL] [Abstract][Full Text] [Related]
23. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz CE; Tett SE
Clin Pharmacokinet; 2007; 46(1):13-58. PubMed ID: 17201457
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetics of mycophenolic acid and its glucuronide after a single and multiple oral dose of mycophenolate mofetil in Chinese renal transplantation recipients.
Liang MZ; Lu YP; Nan F; Li YP
Transplant Proc; 2006 Sep; 38(7):2044-7. PubMed ID: 16979994
[TBL] [Abstract][Full Text] [Related]
25. Atypical pharmacokinetics and metabolism of mycophenolic acid in a young kidney transplant recipient with impaired renal function.
Wigger M; Armstrong VW; Shipkova M; Wacke R; Nizze H; Streit F; von Ahsen N; Muscheites J; Glasenapp S; Stolpe HJ; Oellerich M
Ther Drug Monit; 2002 Jun; 24(3):438-43. PubMed ID: 12021639
[TBL] [Abstract][Full Text] [Related]
26. Comparison of pharmacokinetics of mycophenolic acid and its glucuronide between patients with lupus nephritis and with kidney transplantation.
Mino Y; Naito T; Matsushita T; Otsuka A; Ushiyama T; Ozono S; Hishida A; Kagawa Y; Kawakami J
Ther Drug Monit; 2008 Dec; 30(6):656-61. PubMed ID: 18978521
[TBL] [Abstract][Full Text] [Related]
27. Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus.
Patel CG; Harmon M; Gohh RY; Akhlaghi F
Ther Drug Monit; 2007 Feb; 29(1):87-95. PubMed ID: 17304155
[TBL] [Abstract][Full Text] [Related]
28. Cyclosporine concentration-dependent increase in concentration ratio of mycophenolic acid acyl and phenol glucuronides to mycophenolic acid in stable kidney transplant recipients.
Mino Y; Naito T; Otsuka A; Ushiyama T; Ozono S; Kagawa Y; Kawakami J
Clin Biochem; 2009 May; 42(7-8):595-601. PubMed ID: 19100248
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics, efficacy, and safety of mycophenolate mofetil in combination with standard-dose or reduced-dose tacrolimus in liver transplant recipients.
Nashan B; Saliba F; Durand F; Barcéna R; Herrero JI; Mentha G; Neuhaus P; Bowles M; Patch D; Bernardos A; Klempnauer J; Bouw R; Ives J; Mamelok R; McKay D; Truman M; Marotta P
Liver Transpl; 2009 Feb; 15(2):136-47. PubMed ID: 19177449
[TBL] [Abstract][Full Text] [Related]
30. [Optimal immunosuppressive therapy based on pharmacokinetics and pharmacodynamics of antimetabolites in clinical practice].
Naito T
Yakugaku Zasshi; 2010 Dec; 130(12):1695-700. PubMed ID: 21139397
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of tacrolimus and mycophenolate mofetil in renal transplant recipients on a corticosteroid-free regimen.
Greanya ED; Poulin E; Partovi N; Shapiro RJ; Al-Khatib M; Ensom MH
Am J Health Syst Pharm; 2012 Jan; 69(2):134-42. PubMed ID: 22215359
[TBL] [Abstract][Full Text] [Related]
32. Total and free mycophenolic acid and its 7-O-glucuronide metabolite in Chinese adult renal transplant patients: pharmacokinetics and application of limited sampling strategies.
Jiao Z; Zhong JY; Zhang M; Shi XJ; Yu YQ; Lu WY
Eur J Clin Pharmacol; 2007 Jan; 63(1):27-37. PubMed ID: 17093994
[TBL] [Abstract][Full Text] [Related]
33. Differences in clearance of mycophenolic acid among renal transplant recipients, hematopoietic stem cell transplant recipients, and patients with autoimmune disease.
de Winter BC; Mathot RA; Sombogaard F; Neumann I; van Hest RM; Doorduijn JK; van Gelder T
Ther Drug Monit; 2010 Oct; 32(5):606-14. PubMed ID: 20720518
[TBL] [Abstract][Full Text] [Related]
34. Clinical efficacy and toxicity profile of tacrolimus and mycophenolic acid in relation to combined long-term pharmacokinetics in de novo renal allograft recipients.
Kuypers DR; Claes K; Evenepoel P; Maes B; Vanrenterghem Y
Clin Pharmacol Ther; 2004 May; 75(5):434-47. PubMed ID: 15116056
[TBL] [Abstract][Full Text] [Related]
35. Dose-normalization for exposure to mycophenolic acid and the early clinical outcome in patients taking tacrolimus after heart transplantation.
Roan JN; Chou CH; Hsu CH; Wu SY; Huang YC; Yang YJ; Luo CY
Ann Transplant; 2013 Feb; 18():43-52. PubMed ID: 23792500
[TBL] [Abstract][Full Text] [Related]
36. Mycophenolic acid pharmacokinetics and related outcomes early after renal transplant.
Atcheson BA; Taylor PJ; Mudge DW; Johnson DW; Hawley CM; Campbell SB; Isbel NM; Pillans PI; Tett SE
Br J Clin Pharmacol; 2005 Mar; 59(3):271-80. PubMed ID: 15752372
[TBL] [Abstract][Full Text] [Related]
37. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W
Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074
[TBL] [Abstract][Full Text] [Related]
38. Time-related clinical determinants of long-term tacrolimus pharmacokinetics in combination therapy with mycophenolic acid and corticosteroids: a prospective study in one hundred de novo renal transplant recipients.
Kuypers DR; Claes K; Evenepoel P; Maes B; Coosemans W; Pirenne J; Vanrenterghem Y
Clin Pharmacokinet; 2004; 43(11):741-62. PubMed ID: 15301578
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and tolerance of mycophenolate mofetil in renal transplant children.
Jacqz-Aigrain E; Khan Shaghaghi E; Baudouin V; Popon M; Zhang D; Maisin A; Loirat C
Pediatr Nephrol; 2000 Feb; 14(2):95-9. PubMed ID: 10684355
[TBL] [Abstract][Full Text] [Related]
40. Increased mycophenolic acid exposure in stable kidney transplant recipients on tacrolimus as compared with those on sirolimus: implications for pharmacokinetics.
Braun F; Schöcklmann H; Ziegler E; Kunzendorf U; Armstrong VW; Renders L
Clin Pharmacol Ther; 2009 Oct; 86(4):411-5. PubMed ID: 19606088
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
